# Rimsys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rimsys

- Industry: Healthcare IT
- Headquarters: Pittsburgh, US
- Website: www.rimsys.io
- Total disclosed funding: $16M
- Latest round: Series A (Dec 2, 2021)
- Investors on record: 4

## About

Rimsys Inc. specializes in Regulatory Information Management solutions tailored for the MedTech sector, enhancing compliance and operational efficiency through a unified cloud-based platform.Founded in 2017, Rimsys Inc. is headquartered in Pittsburgh, US, and focuses on providing regulatory solutions for the MedTech industry. The company was established by Brad Ryba and James Gianoutsos, who have backgrounds in regulatory affairs and technology. Rimsys has raised a total of USD 2.00 mn through a Series A funding round as of September 30, 2024, which represents their entire funding to date and positions the company with a current valuation of USD 24.09 mn.Rimsys offers a comprehensive Regulatory Information Management (RIM) platform specifically designed for the MedTech sector. Its core product digitizes and automates regulatory processes, providing a unified cloud-based solution that enables regulatory affairs teams to enhance operational efficiency and mitigate compliance risks. The platform includes features such as the creation and organization of essential regulatory documents, management of global product registrations, tracking of selling status, and collaboration tools for authoring regulatory applications. Rimsys serves a diverse clientele, including medical device manufacturers and healthcare organizations across North America, Europe, and select markets in Asia-Pacific. By consolidating critical regulatory information into a 'single source of truth,' Rimsys ensures that all stakeholders have access to consistent and up-to-date data, thereby streamlining the path to market for medical products.The revenue model for Rimsys is primarily subscription-based, where clients engage the platform through various pricing tiers that accommodate different levels of service and functionality. Customers typically enter into annual agreements that provide access to the RIM platform and its full suite of features, including regulatory document management and compliance monitoring tools. Transactions occur directly between Rimsys and its clients, predominantly B2B, where regulatory affairs teams within medical device companies utilize the software to meet compliance and market entry requirements. Specific details about pricing plans or flagship services have not been disclosed; however, the platform's comprehensive functionalities are designed to support clients in managing their regulatory landscape efficiently.Rimsys Inc. intends to leverage the recent USD 2 million raised in Series A funding to enhance its platform and support future product developments. The company is planning to introduce additional features aimed at streamlining regulatory processes further, with prospective launches anticipated in 2025. Furthermore, Rimsys is targeting expansion into new geographical markets, particularly focusing on regions in Europe and Asia-Pacific by mid-2025, which aligns with its strategy to enhance its global footprint.

## Funding rounds

- Series A, Dec 2, 2021, $16M — Bessemer Venture Partners, Allos Ventures, Innovation Works, Private Opportunities

## Investors

- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series A
- Allos Ventures (https://capitalatlas.ai/funds/allos-ventures) — Series A
- Innovation Works (https://capitalatlas.ai/funds/innovation-works) — Series A
- Private Opportunities — Series A